2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 11.683 | 0 | 0 | 0 | 0 | 327.090 | 0 | 126.855 | 3.909.836 | 1.031.801 |
Total Income - EUR | 16.226 | 0 | 139 | 0 | 0 | 328.340 | 626.271 | 1.644.095 | 2.438.172 | 1.716.123 |
Total Expenses - EUR | 20.449 | 8.802 | 835 | 0 | 0 | 266.725 | 606.778 | 1.638.495 | 2.409.005 | 1.646.106 |
Gross Profit/Loss - EUR | -4.223 | -8.802 | -695 | 0 | 0 | 61.614 | 19.492 | 5.600 | 29.167 | 70.017 |
Net Profit/Loss - EUR | -4.574 | -8.802 | -695 | 0 | 0 | 58.938 | 19.342 | 4.454 | 4.228 | 60.292 |
Employees | 2 | 2 | 0 | 0 | 0 | 11 | 36 | 42 | 46 | 27 |
Check the financial reports for the company - Biobuilds S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 1.947 | 1.963 | 1.943 | 1.910 | 1.875 | 147.378 | 560.700 | 926.963 | 1.352.962 | 1.247.849 |
Current Assets | 12.804 | 12.955 | 12.675 | 12.461 | 12.232 | 601.242 | 1.953.489 | 4.011.308 | 2.634.456 | 2.608.810 |
Inventories | 380 | 383 | 379 | 372 | 365 | 240.002 | 1.677.188 | 3.587.686 | 2.365.155 | 2.469.952 |
Receivables | 12.320 | 12.423 | 12.296 | 12.088 | 11.867 | 295.428 | 213.027 | 365.236 | 251.920 | 113.656 |
Cash | 105 | 150 | 0 | 0 | 0 | 65.812 | 63.274 | 58.386 | 17.381 | 25.201 |
Shareholders Funds | 6.130 | -2.620 | -3.289 | -3.233 | -3.174 | 55.826 | 29.679 | 33.475 | 37.806 | 219.605 |
Social Capital | 11.155 | 11.249 | 11.134 | 10.945 | 10.745 | 10.537 | 10.337 | 10.108 | 10.139 | 131.730 |
Debts | 8.621 | 17.539 | 17.907 | 17.604 | 17.281 | 692.794 | 2.494.023 | 4.932.019 | 3.920.742 | 3.609.958 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43.192 | 35.783 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "1629 - 1629" | |||||||||
CAEN Financial Year |
1629
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Biobuilds S.r.l.